PUBLIC COMPANY
saveMylan Pharmaceuticals Inc
updated 1mo ago
Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.
community read0 votes
pipeline
49
marketed
48
phase 3
0
catalysts ytd
9
approvals ytd
7
recalls ytd
0
Pipeline(49)
view full pipeline →pipeline depth49 products
48Marketed1Unknown
Marketed
(amiloride hydrochloride + hydrochlorothiazide)
Congestive Heart Failure (Heart Failure)
Marketed(amitriptyline + chlordiazepoxide)
Depression
Marketed(amitriptyline hydrochloride + perphenazine)
Anxiety Disorders
Marketed(amlodipine besylate + telmisartan)
Hypertension
Marketed(ampicillin sodium + sulbactam sodium)
Complicated Intra-Abdominal Infections
Upcoming
no upcoming catalysts on record
Recent(90d)
drug shortage (2)
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that